And despite all GLP-1 agonists can do, theres no silver bullet for weight loss
With A1C reductions up to 2.24%, tirzepatide offers the most potent glucose-lowering effect of any incretin-based therapy currently available
Primarily used in the management of type 2 diabetes, it plays a crucial role in blood sugar regulation
TZP was superior to dulaglutide in GC and reduction of BW and the safety report of TZP was coherent with that of dulaglutide (80)
A., Lunardi, G., Doimo, M., Trevisson, E., & Salviati, L
Ehling R, Di Pauli F, Lackner P, Rainer C, Kraus V, Hegen H, Lutterotti A, Kuenz B, De Zordo T, Schocke M, Glatzl S, Loscher WN, Deisenhammer F, Reindl M, Berger T (2015) Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: a prospective observational clinical trial